University of Nebraska Medical Center

Andrew M. Goldsweig, MD, MS, FACC, FSCAI, FSVM, RPVI

Associate Professor, Division of Cardiovascular Medicine
Associate Cath Lab Director for Structural Heart Disease
Governor, Nebraska Chapter, American College of Cardiology

Andrew M. Goldsweig, MD, MS, FACC, FSCAI, FSVM, RPVI

Dr. Goldsweig is an associate professor and medical director for structural heart disease at the University of Nebraska Medical Center. Clinically, he performs TAVR, TEER, LAAO, PFO/ASD/VSD and paravalvular leak closure and PCI.

Dr. Goldsweig serves as Governor of the Nebraska American College of Cardiology Chapter and is a member of the NCDR LAAO Registry Steering Committee and HeartPAC Executive Board. He is a member of the SCAI Structural Heart Disease Council, Publications Committee, and Government Relations Committee, representing SCAI on the AMA CPT Panel. He is an associate editor for JSCAI and an editorial board member for Circulation: Cardiovascular Interventions, Catheterization and Cardiovascular Interventions, American Heart Journal, and Cardiovascular Revascularization Medicine.


  • BS: Chemistry and Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, 1999-2003
  • Medical school: New York University, 2003-2009
  • Residency: Internal Medicine, Yale University, 2009-2012
  • Fellowship: Cardiovascular Disease, Yale University, 2012-2015
  • Fellowship: Interventional Cardiology, Yale University, New Haven, Connecticut, 2015-2016
  • Fellowship: Structural Heart Disease, Brown University, Providence, Rhode Island, 2016-2017
  • MS: Clinical Translational Research, University of Nebraska Medical Center, 2018-2020
  • Certifications
    Interventional Cardiology
    Cardiovascular Disease
    Internal Medicine
Research interests include structural heart disease outcomes and clinical trials. He serves on the MINT trial international steering committee and as site PI for 10 trials including TAVR UNLOAD, Optimize PRO, CHAMPION-AF, ASAP-TOO, TRANSCEND, PARADIGM, OCCLUFLEX, and National Cardiogenic Shock Initiative.